Pharma News Intelligence October 6, 2020
In collaboration with the Gates Foundation, top pharmaceutical companies made a commitment to expand global access to COVID-19 vaccines, diagnostics, and therapeutics.
AstraZeneca, Gilead, Johnson & Johnson, and other major pharmaceutical companies recently backed efforts to expand global access to COVID-19 vaccines, diagnostics, and therapeutics.
In a joint statement released by the Bill & Melinda Gates Foundation, the companies extolled pandemic research and development efforts, such as the creation of novel COVID-19 treatments and vaccines. But said the innovations are not enough to stop the pandemic, they said.
“Through partnerships with other stakeholders we are committed to ensuring global access to diagnostics, therapeutics, and vaccines that will help to accelerate the end of the pandemic,” the joint statement read.
To...
Today's Sponsors
Today's Sponsor